Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).

David S KesslerStephanie J MacNeillDeborah TallonGlyn LewisTim J PetersWilliam HollingworthJeff RoundAlison BurnsCarolyn A Chew-GrahamIan M AndersonTom ShepherdJohn CampbellChris M DickensMary CarterCaroline JenkinsonUna MacleodHelen GibsonSimon DaviesNicola J Wiles

Published in: BMJ (Clinical research ed.) (2018)

Current Controlled Trials ISRCTN06653773.

Keyphrases

phase iii
double blind
primary care
placebo controlled
clinical trial
open label
cell proliferation
long non coding rna
study protocol
phase ii
long noncoding rna
depressive symptoms
sleep quality
general practice
physical activity